Systemic inflammation, oligodendroglial maturation, and the encephalopathy of prematurity

Annals of Neurology

Volumn 70, Issue 4, 2011, Pages 525-529

  Volpe, Joseph J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CAFFEINE; GAMMA INTERFERON RECEPTOR; HYALURONIC ACID; INTERLEUKIN 1BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

AMNESIA; ANISOTROPY; ASTROCYTOSIS; ATTENTION; BASAL GANGLION; BRAIN CORTEX; BRAIN DISEASE; CALCIUM TRANSPORT; CELL DEATH; CELL SURVIVAL; EXCITOTOXICITY; HUMAN; INFLAMMATION; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE FIBER DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PERIVENTRICULAR HETEROTOPIA; PRIORITY JOURNAL; PYRAMIDAL TRACT; REVIEW; THALAMUS; VERY LOW BIRTH WEIGHT; WHITE MATTER; WORKING MEMORY; ANIMAL; BRAIN; GROWTH, DEVELOPMENT AND AGING; MYELINATED NERVE; NOTE; PATHOLOGY;

ANIMALS; BRAIN; INFLAMMATION; INTERLEUKIN-1BETA; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA;

EID: 84855374721     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22533     Document Type: Review

References (84)

1. Volpe JJ. Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009; 8:110-124.
2. Aarnoudse-Moens CS, Weisglas-Kuperus N, van Goudoever JB, Oosterlaan J. Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children. Pediatrics 2009;124:717-728.
3. Johnson S, Fawke J, Hennessy E, et al. Neurodevelopmental disability through 11 years of age in children born before 26 weeks of gestation. Pediatrics 2009;124:e249-e257.
4. Johnson S, Hollis C, Kochhar P, et al. Autism spectrum disorders in extremely preterm children. J Pediatr 2010;156:525-531.e2.
5. Roberts G, Anderson PJ, Doyle LW. Neurosensory disabilities at school age in geographic cohorts of extremely low birth weight children born between the 1970s and the 1990s. J Pediatr 2009; 154:829-834.e1.
6. Msall ME. Central nervous system connectivity after extreme prematurity: Understanding autistic spectrum disorder. J Pediatr 2010;156:519-521.
7. Limperopoulos C. Autism spectrum disorders in survivors of extreme prematurity. Clin Perinatol 2009;36:791-805.
8. Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia, PA: Elsevier, 2008.
9. Volpe JJ, Kinney HC, Jensen FE, Rosenberg PA. The developing oligodendrocyte: Key cellular target in brain injury in the premature infant. Int J Dev Neurosci 2011;29:423-440.
10. Eklind S, Mallard C, Leverin A-L, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001;13:1101-1106. (Pubitemid 32275747)
11. Lehnardt S, Massillon L, Follet P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 2003;100:8514-8519. (Pubitemid 36842576)
12. Ikeda T, Mishima K, Aoo N, et al. Combination treatment of neonatal rats with hypoxia-ischemia and endotoxin induces long-lasting memory and learning impairment that is associated with extended cerebral damage. Am J Obstet Gynecol 2004;191:2132-2141. (Pubitemid 39601525)
13. Larouche A, Roy M, Kadhim H, et al. Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: Animal model for perinatally acquired encephalopathy. Dev Neurosci 2005;27:134-142. (Pubitemid 41096219)
14. Wang X, Hagberg H, Nie C, et al. Dual role of intrauterine immune challenge on neonatal and adult brain vulnerability to hypoxia-ischemia. J Neuropathol Exp Neurol 2007;66:552-561. (Pubitemid 46869697)
15. Wang X, Stridh L, Li W, et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009;183:7471-7477.
16. Wang LW, Chang YC, Lin CY, et al. Low-dose lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white matter injury in the immature brain. Pediatr Res 2010;68:41-47.
17. Degos V, Favrais G, Kaindl AM, et al. Inflammation processes in perinatal brain damage. J Neural Transm 2010;117:1009-1017.
18. Favrais G, van de Looij Y, Fleiss B, et al. Systemic inflammation disrupts the developmental program of the white matter. Ann Neurol 2011;70:550-565.
19. Malaeb S, Dammann O. Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol 2009;24:1119-1126.
20. Stolp HB, Ek CJ, Johansson PA, et al. Factors involved in inflammation-induced developmental white matter damage. Neurosci Lett 2009;451:232-236.
21. Jacob A, Brorson JR, Alexander JJ. Septic encephalopathy: Inflammation in man and mouse. Neurochem Int 2011;58:472-476.
22. Terrando N, Monaco C, Ma D, et al. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci U S A 2010;107:20518-20522.
23. Steinman L. Modulation of postoperative cognitive decline via blockade of inflammatory cytokines outside the brain. Proc Natl Acad Sci U S A 2010;107:20595-20596.
24. Hagberg H, Mallard C. Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 2005;18: 117-123. (Pubitemid 40477485)
25. Eklind S, Hagberg H, Wang X, et al. Effect of lipopolysaccharide on global gene expression in the immature rat brain. Pediatr Res 2006;60:161-168. (Pubitemid 44297586)
26. Deng Y, Lu J, Sivakumar V, et al. Amoeboid microglia in the periventricular white matter induce oligodendrocyte damage through expression of proinflammatory cytokines via MAP kinase signaling pathway in hypoxic neonatal rats. Brain Pathol 2008;18:387-400. (Pubitemid 351782848)
27. Fan LW, Mitchell HJ, Tien LT, et al. Interleukin-1beta-induced brain injury in the neonatal rat can be ameliorated by alpha-phenyl-n-tert-butyl- nitrone. Exp Neurol 2009;220:143-153.
28. Volpe JJ. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics 2005;116:221-225.
29. Back SA, Luo NL, Borenstein NS, et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001; 21:1302-1312. (Pubitemid 32128775)
30. Kadhim HJ, Tabarki B, Verellen G, et al. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001; 56:1278-1284. (Pubitemid 32455283)
31. Haynes RL, Folkerth RD, Keefe R, et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes is accompanied by microglial activation in periventricular leukomalacia in the human premature infant. J Neuropathol Exp Neurol 2003;62:441-450. (Pubitemid 36560186)
32. Bell JE, Becher JC, Wyatt B, et al. Brain damage and axonal injury in a Scottish cohort of neonatal deaths. Brain 2005;128:1070-1081. (Pubitemid 40675462)
33. Back SA, Luo NL, Mallinson RA, et al. Selective vulnerability of preterm white matter to oxidative damage defined by F(2)-isoprostanes. Ann Neurol 2005;58:108-120. (Pubitemid 40962466)
34. Robinson S, Li Q, Dechant A, Cohen ML. Neonatal loss of gamma-aminobutyric acid pathway expression after human perinatal brain injury. J Neurosurg 2006;104:396-408. (Pubitemid 44954814)
35. Billiards SS, Haynes RL, Folkerth RD, et al. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 2008;18:153-163. (Pubitemid 351430393)
36. French HM, Reid M, Mamontov P, et al. Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res 2009;87:3076-3087.
37. Billiards SS, Haynes RL, Folkerth RD, et al. Development of microglia in the cerebral white matter of the human fetus and infant. J Comp Neurol 2006;497:199-208. (Pubitemid 43825427)
38. Arumugam TV, Okun E, Tang SC, et al. Toll-like receptors in ischemia-reperfusion injury. Shock 2009;32:4-16.
39. Lehnardt S. Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010;58:253-263.
40. Sloane JA, Blitz D, Margolin Z, Vartanian T. A clear and present danger: Endogenous ligands of Toll-like receptors. Neuromolecular Med 2009;12:149-163.
41. Deng W, Rosenberg PA, Volpe JJ, Jensen FE. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci U S A 2003;100:6801-6806. (Pubitemid 36666660)
42. Jensen FE. Role of glutamate receptors in periventricular leukomalacia. J Child Neurol 2005;20:950-959.
43. Talos DM, Follett PL, Folkerth RD, et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J Comp Neurol 2006;497:61-77. (Pubitemid 43844568)
44. Karadottir R, Attwell D. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 2007;145:1426-1438. (Pubitemid 46602726)
45. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005;438: 1167-1171. (Pubitemid 41831687)
46. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005;438:1162-1166. (Pubitemid 41831686)
47. Micu I, Jiang Q, Coderre E, et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 2006;439:988-992. (Pubitemid 43292418)
48. Matute C. Oligodendrocyte NMDA receptors: A novel therapeutic target. Trends Mol Med 2006;12:289-292. (Pubitemid 44110002)
49. Manning SM, Talos DM, Zhou C, et al. NMDA receptor blockade with memantine attenuates white matter deficits in a rat model of periventricular leukomalacia. J Neurosci 2008;28:6670-6678.
50. Bakiri Y, Burzomato V, Frugier G, et al. Glutamatergic signaling in the brain's white matter. Neuroscience 2009;158:266-274.
51. Sherman LS, Back SA. A 'GAG' reflex prevents repair of the damaged CNS. Trends Neurosci 2008;31:44-52.
52. Back SA, Tuohy TM, Chen H, et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 2005;11:966-972. (Pubitemid 41294442)
53. Sloane JA, Batt C, Ma Y, et al. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A 2010;107:11555-11560.
54. Volpe JJ. Neonatal encephalitis and white matter injury: More than just inflammation? Ann Neurol 2008;64:232-236.
55. Ma Y, Li J, Chiu I, et al. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 2006;175:209-215. (Pubitemid 44631415)
56. Wang H, Katagiri Y, McCann TE, et al. Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J Cell Sci 2008; 121:3083-3091.
57. Cameron JS, Alexopoulou L, Sloane JA, et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 2007;27:13033-13041. (Pubitemid 350159595)
58. Okun E, Griffioen KJ, Mattson MP. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011;34:269-281.
59. LaFerla FM, Sugarman MC, Lane TE, Leissring MA. Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma. J Mol Neurosci 2000;15:45-59. (Pubitemid 32104604)
60. Lin W, Kemper A, Dupree JL, et al. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 2006;129:1306-1318.
61. Folkerth RD, Keefe RJ, Haynes RL, et al. Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol 2004;14:265-274. (Pubitemid 39095988)
62. Back SA, Craig A, Ling Luo N, et al. Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann Neurol 2006;60:696-705. (Pubitemid 46048487)
63. Segovia KN, McClure M, Moravec M, et al. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann Neurol 2008;63:520-530. (Pubitemid 351614718)
64. Davis PG, Schmidt B, Roberts RS, et al. Caffeine for apnea of prematurity trial: Benefits may vary in subgroups. J Pediatr 2010;156: 382-387.
65. Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357: 1893-1902. (Pubitemid 350074685)
66. Cannella B, Raine CS. Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol 2004; 55:46-57. (Pubitemid 38067360)
67. Jana M, Pahan K. Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes. Free Radic Biol Med 2005;39:823-831. (Pubitemid 41139895)
68. Vela JM, Molina-Holgado E, Arevalo-Martin A, et al. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci 2002;20:489-502. (Pubitemid 34971563)
69. Su Z, Yuan Y, Chen J, et al. Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-α. J Neurotrauma 2011;28:1089-1100.
70. Haynes RL, Borenstein NS, DeSilva TM, et al. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol 2005;484:156-167. (Pubitemid 40321843)
71. Haynes RL, Billiards SS, Borenstein NS, et al. Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr Res 2008;63:656-661.
72. Andiman SE, Haynes RL, Trachtenberg FL, et al. The cerebral cortex overlying periventricular leukomalacia: Analysis of pyramidal neurons. Brain Pathol 2010;20:803-814.
73. Pierson CR, Folkerth RD, Billards SS, et al. Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol 2007;114:619-631. (Pubitemid 350142750)
74. Ligam P, Haynes RL, Folkerth RD, et al. Thalamic damage in periventricular leukomalacia: Novel pathologic observations relevant to cognitive deficits in survivors of prematurity. Pediatr Res 2009; 65:524-529.
75. Kostovic I, Judas M. Correlation between the sequential ingrowth of afferents and transient patterns of cortical lamination in preterm infants. Anat Rec 2002;267:1-6. (Pubitemid 34465292)
76. Ghosh A, Shatz CJ. A role for subplate neurons in the patterning of connections from thalamus to neocortex. Development 1993; 117:1031-1047. (Pubitemid 23113621)
77. McConnell SK, Ghosh A, Shatz CJ. Subplate neurons pioneer the first axon pathway from the cerebral cortex. Science 1989; 245:978-982. (Pubitemid 19224828)
78. Ghosh A, Antonini A, McConnell SK, Shatz CJ. Requirement for subplate neurons in the formation of thalamocortical connections. Nature 1990;347:179-181.
79. Ghosh A, Shatz CJ. Involvement of subplate neurons in the formation of ocular dominance columns. Science 1992;255:1441-1443.
80. Volpe JJ. Subplate neurons-missing link in brain injury of the premature infant? Pediatrics 1996;97:112-113. (Pubitemid 26012619)
81. Kanold PO, Kara P, Reid RC, Shatz CJ. Role of subplate neurons in functional maturation of visual cortical columns. Science 2003; 301:521-525. (Pubitemid 36900310)
82. Kanold PO. Transient microcircuits formed by subplate neurons and their role in functional development of thalamocortical connections. Neuroreport 2004;15:2149-2153. (Pubitemid 39392229)
83. Bystron I, Molnar Z, Otellin V, Blakemore C. Tangential networks of precocious neurons and early axonal outgrowth in the embryonic human forebrain. J Neurosci 2005;25:2781-2792. (Pubitemid 40389236)
84. McQuillen PS, Sheldon RA, Shatz CJ, Ferriero DM. Selective vulnerability of subplate neurons after early neonatal hypoxiaischemia. J Neurosci 2003;23:3308-3315. (Pubitemid 36531972)